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The  third  component  of  human  complement,  C3,  has  been  shown  to  be 
cleaved by its activating enzyme C3 convertase (1)  and by the C3 inactivator 
complex (2)  into two fragments called C3a and C3b  (3,  1). The C3a fragment 
which is the smaller of the two pieces was found to have anaphylatoxin activity 
(3,  4).  Streptokinase-activated plasminogen also  was found to cleave a  small 
fragment off the C3 molecule which,  however, was different from C3a in that 
it exhibited leukocyte chemotactic activity, but no anaphylatoxin activity (5, 
6). 
The present study was initiated  (a)  to investigate cleavage of the native C3 
molecule by a proteolytic enzyme with defined and restricted bond specificity, 
such as trypsin; (b) to isolate and characterize the fragments obtained; and, if 
possible, (c) to relate biological activities to defined fragments of the C3 mole- 
cule. It was found that trypsin cleaves the C3 molecule into at least four distinct 
fragments,  two  of  which  closely  resemble  C3a  and  C3b,  and  that  both  the 
anaphylatoxin and the chemotactic activities are resident in the C3a, although 
in  different  regions of this fragment.  The  C3a  fragment  could be isolated in 
amounts sufficient for  physical  and  chemical  characterization,  and  an  anti- 
serum  capable  of  inhibiting its biological activity could be produced.  In the 
course of this work, an inactivator of anaphylatoxin was found in human serum 
fractions and evidence was obtained,  suggesting that it destroys anaphylatoxin 
activity  by  an  enzymatic  mechanism.  Part  of  the  results  contained  in  this 
communication were presented  earlier in  abridged form (7,  8). 
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Materials  and Methods 
Highly Purified  C3 of Human Serum.~he protein was isolated as described previously (9)" 
Purity was analyzed by Ouchterlony test and  immunoelectrophoresis using a  potent anti- 
whole human serum. Each preparation was also analyzed by disc electrophoresis both at pH 
8.7  (10) and pH 4,5  (11). Preparations which contained detectable impurities were omitted. 
To obtain radioactive C3, the protein was labeled with 12~I or r'~lI by the chloramine T method 
(12). The specific radioactivity varied between 50,000 and 100,000 cpm//~g protein. 
Antisera.~nti-human  C3  was produced by injecting rabbits four times subcutaneously 
with 0.5 mg of the purified protein in complete Freund's adjuvant at 1 wk intervals. Anti-C3a 
was produced by injecting 30 #g  of isolated C3a  in  complete Freund's adjuvant  into the 
popliteal lymph nodes of rabbits and 3 wk later the same material intramuscularly. The anti- 
sera were monospecific  for C3  when tested against whole human serum. Antisera to whole 
human serum were purchased from Behringwerke A.  G.,  Marburg-Lahn, West Germany. A 
sample of antiserum to human a~B was kindly furnished by Dr. Clark West, Cincinnati, Ohio. 
l;mzyme~ and  Enzyme  lnhibitors.  Crystalline trypsin was purchased from Worthington 
Biochemical Corp., Freehold, N. J.; purified plasminogen (13) and thrombin (14) were kindly 
made available by Dr. Fletcher Taylor of the University of Pennsylvania. Streptokinase was 
purchased from American Cyanamid Co., Lederle Laboratories Div., Pearl River, N.  Y.; for 
activation, 500 ~g plasminogen was treated at pH 7.5 at 37°C for 30 min with 1500 units of 
streptokinase. C3 convertase (C4, 2) was generated as described previously (1). C3 inactivator 
complex (C3IC)  was obtained by incubating partially purified C3 serum proinactivator with 
purified cobra factor in the presence of Mg ~+ (2). Soybean trypsin inhibitor (SBTI), Lot No. 
9150, five times crystallized, was purchased from Nutritional Biochemical Corp., Cleveland, 
Ohio,  and diisopropylfluorophosphate (DFP) from Boots Pure Drug Co.,  Ltd., Nottingham, 
England. 
Method  of Formation  and Isolation  of C3a and  C3b.~hree  different procedures were used 
for the isolation of C3a:  Sephadex filtration, preparative gel electrophoresis, and free flow 
electrophoresis. The sample applied contained approximately 50 mg of a mixture of purified, 
unlabeled C3 and of ~25I-C3 which had been treated at a concentration of 1 mg/ml with 1% 
trypsin (w/w) for 60 sec at 20°C and pH 7.6. The reaction was stopped by addition of SBTI 
in an amount twice that of trypsin present. The sample was then acidified with 1.0 N HC1 to 
pH 3.5. Since some of the C3b fragment precipitates upon acidification,  the sample was cleared 
by brief centrifugation and then concentrated to approximately 5 ml using an Amicon pressure 
filtration device and the ultrafilter UM-05. After separation of the material, the C3a fragment 
was detected by anal3~ing  the collected  fractions for radioactivity, and fractions containing 
C3a were pooled and concentrated as outlined above. Approximately 2 mg C3a were obtained 
from 50 mg C3. 
Sephadex filtration was carried out using a 90 X  2.5 cm column of Sephadex G-100 which 
was equilibrated with 0.15 M acetate buffered sodium chloride, pH 3.6. This buffer consisted 
of nine parts 0.01 ~  acetic acid,  one part 0.01 M sodium acetate, and 8.78 g of NaCl/liter. 
Five ml of sample was layered between the top of the column and the supernatant buffer. 
Filtration was carried out at 4°C with a flow rate of 15 ml/hr and fractions of 3.5  ml were 
collected. 
Preparative gel e]ectrophoresis was performed in a Buchler apparatus using a 2.5 cm sepa- 
rating column of 6% polyacrylamide gel concentration and buffer of pH 4.5 as described by 
Reisfeld et al.  (11). A current of 100 ma was applied, the flow rate was adjusted to i0 ml per 
hour and fractions of 2.5 ml were collected.  Under these conditions C3a was completely eluted 
after 6 hr. 
Free flow electrophoresis was carried out in a Hannig apparatus  (Electrophoretic separator V.  A.  BOKISCH,  H.  J.  Mt~'LLER-EBERHARD,  C.  G.  COCHRANE  1111 
Model FF,  Brinkmann  Instruments,  Westbury,  New York).  The electrode  buffer  (pH 4.0, 
conductance  7.3  millimhos/cm)  contained  133  g  of sodium acetate  and  280  ml  of concen- 
trated acetic acid in 10 liters of distilled water. The chamber buffer was obtained by dilution 
of the electrode buffer with distilled water to adjust the conductance to 2.2  millimhos/cm. 
The sample was applied into the port next to the anode, the buffer flow in the chamber was 
adjusted to 120 ml/hr and a current of 200 ma was used which corresponded to 1880 v across 
the chamber. 
The C3b fragment was separated from C3a  and small amounts of trypsin and  SBTI  by 
Sephadex filtration of trypsin treated C3  (1% trypsin, w/w, 120 sec, 20°C, pH 7.6) in 0.15 M 
acetate buffered sodium chloride, pH 4.0. C3b appeared in the exclusion volume of the column. 
Method of Formation and Purification of C3c and C3d.  10 mg of C3 (1 mg/ml) were treated 
with 2% trypsin (w/w) in Veronal buffer, pH 7.6, for 60 min at 37°C. The reaction was stopped 
by addition of SBTI in two-fold excess over trypsin. The trypsin-treated C3 was concentrated 
to 2  ml and chromatographed on a  column of Sephadex G-200  (97  X  1.5  cm), equilibrated 
with 0.15  M Veronal-buffered sodium chloride, pH  7.6.  The distribution of C3c and  C3d in 
column fractions was detected by serial Ouchterlony analysis on microscopic slides using an 
antiserum to native C3 and to a  2D. 
Analytical Polyacrylamide Gel Electrophoresis.--This was carried out according to Reisfeld 
(11)  using 6%  resolving gel and  /~-alanine-acetic acid buffer, pH 4.5,  for demonstration of 
C3a and Tris-HC1 buffer, pH 8.7 (10) for the demonstration of C3b, C3c, and C3d. 
Molecular Weight Determinations.  Calculations were made from separate determinations 
of sedimentation (s) and diffusion coefficients (D), assuming a partial specific volume of 0.73 
for all proteins. This value was derived from the amino acid compositions of both C3 and C3a 
(15).  D  was  estimated  according to  Andrews  (16)  employing columns of  Sephadex  G-200 
equilibrated with 0.15 M Tris-HC1 buffer, pH 8.2.  As reference substances were used, equine 
cytochrome C  (13  X  10  -7 cm2/sec), hemoglobin (6.8  X  10  -7 cm2/sec), laI 3,G-globulin  (3.8 
X  10  -7 cm2/sec)  and laI  thyroglobulin  (2.5  X  10  _7 cm2/sec), s was estimated by ultracen- 
trifugation in a 3.85-15.5% linear sucrose density gradient in an L2 Spinco machine using an 
SW39 or SW50 rotor. 0.1 M Tris-HC1 buffer, pH 8.2, was used for most experiments; for the 
analysis of C3a,  a  calibrated  Sephadex  G-100 column was used,  equilibrated with acetate- 
buffered sodium chloride of pH 3.6.  Reference substances were 1311 yG-globulin (7S), hemo- 
globin (4.6S), not used in experiments where a low pH was employed, and equine cytochrome 
C  (1.7S). 
The mol wts of C3 and C3a were also determined according to Archibald by approach to 
sedimentation equilibrium using the method described by Trautman  (17).  C3 was analyzed 
in phosphate buffer, pH 7.0, T/2  (ionic strength)  =  0.1,  at a  concentration of 7.8 mg/ml at 
15,220  and at 8,766 rpm and 20°C. C3a was examined at 5.8 mg/ml in 0.15 M acetate-buffered 
sodium chloride, pH 3.6,  and 20°C at  52,640  rpm and at 39,460  rpm. The resulting c,,  --c  ° 
versus qm plot from which the tool wt of C3a was calculated is shown in Fig. 1. 
Demonstration of Biological  Activity.--The ability of fragments to contract the guinea pig 
ileum and to cause changes in vascular permeability was tested as described earlier (4). Chemo- 
tactic  activity  was  determined  with  rabbit  polymorphonuclear  leukocytes  according  to 
published methods (6). 
Purification  of  an  Anaphylatoxin  Inactivator from  Human  Serum.--Human  blood  was 
allowed to clot for 4 hr and the clot was removed by centrifugation. To remove the euglobulins, 
the serum was dialyzed for 48 hr against 10 liters of 8 X  10  -3 ~  Na3 EDTA  1 of pH 5.4, having 
a  conductance of 1.25  millimhos/cm.  10 ml of the supernatant pseudoglobulin fraction was 
subjected to Pevikon block electrophoresis in barbital buffer, pH 8.6, T/2  =  0.05, for 24 hr 
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at 4°C using a  potential gradient of 4  v/cm. Fractions containing anaphylatoxin inactivator 
activity were pooled,  concentrated  to  approximately 2  m] and applied  to  a  Sephadex  G-200 
column (97)<  1.5 cm) equilibrated with 0.15 M Tris-HC1 buffer, pH 8.0.  The flow  rate was 
adjusted to  8  ml/hr and fractions of 1.7 ml were collected and tested for inhibitory activity. 
The active fractions were  pooled,  concentrated,  and subjected  to  analytical polyacrylamide 
gel electrophoresis in 6% gels and at pH 8.7.  Several gels were utilized; two were stained for 
proteins.  The others were  left unstained and cut into  2  mm segments, each of which were 
eluted with veronal-buffered sodium chloride, pH 7.6, and tested for inactivating activity. 
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FIG.  1.  c~  -- c ° vs. qm plot for the tool wt determination of isolated C3a by the approach 
to  sedimentation  equilibrium  method.  The  protein  was  analyzed  at  5.8  mg/ml  in  0.15  M 
acetate-buffered sodium chloride,  pH 3.6,  at  20°C  and  39,460 rpm  (solid  circles)  and  52,640 
rpm  (open  circles).  M  (1  --  ~)  =  slope of line.  By  least  square method  y  =  --1761.8  x 
+10045.6.  (~  =  partial specific volume). 
A naphylatoxin [nactivator A ssay.--lO ~g of C3a were allowed to react with 0.1 ml of various 
column fractions for 4  rain at pH  7.0 and 20°C.  C5 derived  anaphylatoxin was obtained  by 
trypsin treatment of isolated C5 as described previously (4).  150 #g of treated but unseparated- 
C5 was then allowed to react with 0.1 ml of the column fractions as above. The reaction mix- 
tures were tested for anaphylatoxin activity on sensitized guinea pig ileum as described else 
where  (4). 
Nomenclature.  Symbols  and  terms used  in  this publication  were  recommended  by  the 
World Health Organization Committee on Complement Nomenclature, Boston,  1968.  The 
recommended changes of the previously used nomenclature (18)  include deletion of the prime 
from the complement symbol (i.e.,  C  instead of C')  and deletion of "a"  as indication for an 
activated complement component. Enzyme activity may be indicated  by placing a  bar above 
the numeral which refers to the component in which the activity resides. Thus, C3 convertase 
may be denoted  C4,2. Fragments of components resulting from cleavage by enzymes are de- v.  A.  BOKISCH,  H.  J.  MULLER-EBERHARD,  C.  G.  COCHRANE  1113 
noted with a small letter, e.g., C3a, C3b, C3c, and C3d. Inactivated components or inactivated 
products of components may be designated with the small letter "i". 
RESULTS 
I.  Cleavage of Native  C3 into Four Fragments by Trypsin.-- 
A.  Demonstration  of the C3 fragments:  Treatment of native C3  with trypsin 
for 60 sec at room temperature resulted in an increase of electrophoretic mobility 
and in complete loss  of hemolytic activity. Immunoelectrophoresis detected  a 
major product which resembled the previously described C3i (19)  (Fig. 2, top). 
Disc electrophoresis at pH 4.5 revealed a second, minor product which migrated 
rapidly toward the cathode  (Fig. 2, bottom). The minor fragment was detected 
FIG. 2.  Demonstration of C3a by acid polyacrylamide gel electrophoresis  following treat- 
ment of C3 with trypsin (1%, w/w, 60 sec, 20°C, pH 7.6). Upper panel: immunoelectrophoresis 
of (a) native C3 and (b) trypsin treated C3. Anode was at the right; pattern was developed 
with rabbit anti-human C3. Lower panel: electrophoresis  in 6% polyacrylamide gel at pH 4.5. 
(c) 200 ug of native C3,  (d) 200 ug of trypsin treated C3. The cathode was at the right. The 
lower gel  (d)  shows  C3a  as a cathodically migrating protein band. The dark areas near the 
anodal end of the gels represent native C3 and C3b, respectively.  Identical results were  ob- 
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without exception in replicate experiments, but was never observed when native 
C3 was subjected to disc electrophoresis. It will be referred to as C3a, and the 
product resembling C3i will  be called C3b. 
Treatment of C3 with trypsin for 1 hr at 37°C resulted in degradation of the 
initially liberated C3a fragment and in cleavage of the C3b fragment into two 
pieces, C3c and C3d, which were readily demonstrable by immunoelectrophore- 
sis (Fig. 3). 
B.  Isolation of the C3fragments: Utilizing 125I-labeled, isolated C3 and limited 
trypsin treatment (60 sac, 20°C), C3a was separated from C3b at acid pH either 
by filtration on Sephadex G-100 (Fig. 4),  by preparative polyacrylamide gel 
electrophoresis (Fig. 5), or by preparative free flow electrophoresis in a Hannig 
apparatus  (not shown).  C3a purified by these methods  appeared  as a  single 
disc  when  analyzed  by  analytical  polyacrylamide gel  electrophoresis at  pH 
4.5,  as shown  in  Fig.  5.  Dissociation  of the a-fragment from cleaved C3  re- 
quired acid pH; it did not occur at pH 7. 
After prolonged trypsin treatment of native C3  (60 rain,  37°C),  the c- and 
the d-fragment were separated by filtration on Sephadex G-200,  as shown in 
Fig. 6. 
C.  Physicochemical  and  immunologic  characterization  of  the  C3 fragments: 
Values for sedimentation and diffusion coefficients and for the tool wts of the 
fragments  are  listed  in  Table  I.  For  comparison,  respective parameters  for 
native C3 are also listed. The mol wt data are in good agreement with the rela- 
tive yield of the fragments, which for the a-, b-, c- and d-fragments was found 
to be 5 %,  95 %,  60%,  and  14%,  respectively. Fission of the b-fragment was 
invariably accompanied by liberation of dialyzable peptides which accounted 
for approximately 20% of the starting material. The tool wts of C3 and C3a were 
also determined by the Archibald method. The discrepancy in values obtained 
for native C3  by different methods, although unexplained, is presumed to be 
methodological in nature.  Fig.  7 shows schlieren patterns of C3a which  were 
photographically recorded during analytical ultracentrifugation. 
The electrophoretic mobility of the  small  C3a  fragment differed strikingly 
from that  of any protein of serum. As illustrated in Fig.  8,  C3a migrated on 
cellulose acetate strips at pH 8.6 toward the cathode, whereas the ~,-globulin 
fraction of  a  reference serum  moved from the  origin  toward  the  anode.  In 
contrast, C3c and C3d differed little in electrophoretic behavior and resembled 
C3b  (Fig.  3).  C3d  appears  to  be  electrophoretically heterogeneous.  Further 
treatment with trypsin for 15 rain converted C3a to a product which at pH 8.6 
was negatively charged and migrated as a broad zone with the electrophoretic 
mobility of the B-globulin fraction (Fig.  8). 
When isolated C3a was  analyzed with anti-C3  by capillary precipitin test, 
turbidity developed within 10 rain and a flocculent precipitate became visible 
after several hr. A  definite precipitin line could be seen upon analysis of C3a 
with either anti-C3 or anti-C3a in Ouchterlony plates (Fig. 9). The precipitin V.  A.  BOKISCH~ tI.  j.  MI~ILLER-EBERHARD, C.  G.  COCHRANE  1115 
FIG. 3.  Immunoelectrophoretic demonstration of fragments C3b, C3c,  and C3d.  C3b was 
obtained by treatment of C3 with 1% (w/w) trypsin for 60 sec at 20°C (C3a not detectable). 
C3c and C3d were obtained by treatment of C3 with 2% trypsin (w/w) for 60 min at 37°C. 
These fragments were separated by Sephadex G-200 filtration. The anode was to the right; 
patterns were developed with rabbit anti-human C3. 
Fro. 4.  Isolation of C3a by Sephadex G-100 filtration and correlation of the distribution of 
C3a with  anaphylatoxin and  chemotactic activity.  30  mg purified  C3  containing a  small 
amount of 125I-C3 was applied to the column after treatment with 1% trypsin (w/w) for 60 
sec at 20°C. The column was equilibrated with 0.15 M acetate buffered sodium chloride, pH 
3.6.  Solid  line  shows distribution of  radioactivity in  fractions, bars  indicate chemotactic 
activity, the symbol +  shows anaphylatoxin activity. C3b,  the first peak, emerged with the 
exclusion  fraction; C3a accounted for the second peak as shown by acid disc electrophoresis 
of fraction samples (insert: discs in fractions 31-46 in lower part of gels constitute C3a).  The 
third peak was caused by free 1~I and a negligible amount of small peptides. 1116  c3a  FRAGMENT  OF  THIRD  COMPONENT  OF  HUMAN  COMPLEMENT 
FIG.  5.  Isolation of C3a by preparative polyacrylamide gel electrophoresis using a Buchler 
column. 30 mg purified C3 containing trace amounts of mI-C3 was applied to the column after 
treatment with 1% trypsin (w/w) for 60 see at 20°C. The resolution gel was 2.5  cm long, the 
gel concentration 6%, the pH 4.5,  the current 100 ma, and the time of electrophoresis 15 hr. 
The cathode was located  at  the bottom of the column corresponding to the left side of the 
graph.  C3a emerged after approximately 6 hr,  C3b was still inside the gel at the end of the 
experiment. Fractions of the major peak were pooled, concentrated, and the protein analyzed 
by acid disc electrophoresis (insert). 
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FIG.  6.  Separation of C3c and C3d by filtration of Sephadex G-200.  10 mg C3 containing 
a small amount of 125I-C3 was applied after treatment with 2% trypsin (w/w) for 60 min at 
37°C. The  column was equilibrated with 0.15  M veronal-buffered sodium chloride, pH  7.6. 
The distributions of the c- and d-fragment were detected by antisera to C3 and c~2D (not shown). 
To avoid cross contamination, fractions were pooled as indicated. V.  A.  BOKISCH~  H.  ~'.  MULLER-EBERHARD~ C.  G.  COCHRANE 
TABLE I 
Molecular Parameters of C3 and C3 Fragments 
1117 
Fragment 
Native C3 
C3a 
C3b 
C3c 
C3d 
D  $ 
9.5  3.6* 
1.1 
9.0§  3.6* 
6.7§  4.0* 
2.6§  8.6* 
Molecular weight 
Calculated from 
s  and D 
235,000 
8,700~ 
223,000 
151,000 
27,000 
Archibald  method 
180,000 
7,000 
* Sephadex  G-200 filtration. 
:~ Determined with calibrated Sephadex  G-100 column. 
§ Sucrose density gradient ultracentrifugation. 
FIG. 7.  Schlieren patterns of isolated C3a obtained during analytical ultracentrifugation. 
Protein concentration, 5.8 mg/ml; solvent, 0.15 M acetate-buffered sodium chloride,  pH 3.6; 
temperature, 20°C; phase-plate angle at 64 min, 50  °, at 128 and 256 rain, 45°; speed, 52,640 
rpm. 
patterns indicated that  C3a is antigenically distinct from  C3b  2 and that  both 
antigenic entities are recognizable in the native C3 molecule. They also showed 
that  the  antigenic deficiency of  C3b  relative to  native  C3  is not entirely ac- 
2 Unless C3b is passed over Sephadex at acid pH (4.0), it is loosely complexed with C3a and 
yields a positive reaction with anti-C3a. A lower pH should be avoided,  as it destroys the 
reactivity of C3b with antibody. 1118  c3a  FRAGMENT  OF  THIRD  COMPONENT  OF  HUMAN  COMPLEMENT 
Fit;. 8.  Demonstration  of basic character  of isolated C3a by electrophoresis on cellulose 
acetate at pH 8.6. The figure is a composite of three electrophoretic strips which were subjected 
to  electrophoresis under identical conditions on different days. The upper strip  shows the 
cathodal migration of C3a relative to C3 and C3b. The strip in the middle shows the electro- 
phoretic behavior of C3a relative to whole human serum and C3. The lower strip illustrates 
the effect of trypsin (15 min, 37°C, 4% and 8% [w/w]) on the mobility of C3a. Three different 
preparations of C3a were used. The arrow indicates the site of application. 
counted for by the lack of the small a-fragment. This was also shown in other 
experiments in which absorption of anti-C3 with purified C3a did not abolish 
the characteristic spurring of the C3 precipitin line over the C3b line. Analysis 
of the purified fragments C3c and C3d by Ouchterlony test using an anti-C3 
antiserum showed  that  both fragments were  antigenically distinct, since the 
precipitin pattern gave the reaction of non-identity (Fig. 10). Further, C3c gave 
a  reaction  of  identity with  ¢~lA-globulin  isolated  from  aged  serum  and  C3d 
(but not C3c)  reacted with antiserum to a2D. v.  A.  BOKISCtI,  H.  J.  M1JLLER-EBERHARD,  C.  G.  COCHRANE  1119 
II.  Studies  of the Biological Activities  of the C3a Fragment.-- 
A.  Anaphylatoxin  and  chemotactic activity of C3a  produced by  trypsin:  C3 
(1 mg/ml) treated with trypsin for various periods of time  3 was tested for smooth 
FIG. 9.  Demonstration  of  antigenic  difference  between  C3a  and  C3b  by  Ouchterlony 
analysis. The drawings below the photographs were made according to visual inspection of 
the agar plates and emphasize the essential phenomena, which cannot be seen clearly in the 
photographic record. The precipitin line resulting from C3a and anti-C3 crossed  the C3b-anti- 
C3 line.  Anti-C3a reacted with C3a and  C3  and both lines fused completely, but it did not 
react with C3b. The identity of the lines near the C3 wells is unknown. 
muscle  contracting  activity.  Definite  activity was  reproducibly  demonstrated 
and,  as listed in Table II, maximal activity was  observed after  1 min at  20°C. 
In  other  experiments,  using  C3  in  concentrations  of  10  mg/ml,  activity  was 
seen as early as 6  sec after  addition  of trypsin.  The  active principle  was  itself 
sensitive to the effects of trypsin  and  was  no longer detectable  after  5  min of 
3 Following treatment with trypsin,  SBTI was added  and the samples were then acidified 
with 0.1 N  HC1 to pH 3.5. 1120  c3a  FRAGMENT  OF  THIRD  COMPONENT  OF  ItUMAN  COMPLEMENT 
trypsin treatment.  The  active material also produced increased vascular per- 
meability in  guinea  pig and  rabbit  skin,  and  both  biological effects  were  in- 
hibitable by anti-histamine. In addition, trypsin treated C3  caused histamine 
release from isolated rat peritoneal mast cells. 
Fro. 10.  Ouchterlony  analysis showing antigenic distinctness  of C3c and C3d. Center well: 
anti-C3. 
TABLE  II 
Generation  of  Anaphylatoxln  and  Chemotactic Activity from  C3  by  Trypsin  as  a  Function 
of Time at 20°C 
Time of treatment* with trypsin  Anaphylatoxin activity  Chemotactic value 
30 sec 
1 min 
2  ~ 
5  u 
10  " 
30  " 
+++ 
++++ 
+++ 
+ 
63 
110 
103 
98 
115 
112 
* 1 mg C3  in  1 ml  0.15 M Veronal-buffered  sodium  chloride,  pH  7.6, was  treated with 
1% trypsin (w/w).  Reaction was stopped by addition of SBTI. 
Chemotactic activity for polymorphonuclear leukocytes also appeared upon 
treatment  of purified C3 with trypsin (Table II). The development of chemo- 
tactic activity followed approximately the time course of generation of anaphy- 
latoxin. Maximal activity was  observed after  1 min  at  20°C,  coincident  with 
complete  conversion  and  loss  of hemolytic activity of  C3  and  with  maximal 
liberation of the C3a fragment. Unlike anaphylatoxin, chemotactic activity was V.  A.  BOKISCtI~  H.  J.  MULLER-EBERHARD,  C.  G.  COCtIRANE  1121 
resistant  to  further  trypsin  treatment  up  to  1  hr  at  20°C,  at  which  time  it 
gradually decreased. 
Filtration of  trypsin  treated  125I-C3 containing  anaphylatoxin  and  chemo- 
tactic activity on a  Sephadex G-100 column showed that both activities had a 
FIo. 11.  Acid polyacrylamide gel electrophoresis  demonstrating formation of basic frag- 
ment by treatment of native C3 with various enzymes. 150-200/zg of C3 were applied to each 
gel; the gel concentration was 6% and the pH was 4.5. Contr., untreated C3; Try., 1% trypsin 
(w/w), 30 seconds, 20°C; Conv., C3 convertase, 30 rain, 37°C; C3IC, C3 inactivator complex, 
30 rain, 37°C; Plasm.,  plasmin,  100 ~g, 30 rain, 37°C; Throm., thrombin, 50 N.I.H.* units, 
30 rain, 37°C. All controls  (not shown) lacking enzyme appeared like untreated C3, and all 
enzyme samples lacking C3 gave patterns which accounted  for the additional protein bands 
seen in the treated samples but not in the untreated control,  except the band  labeled C3a. 
* National Institutes of Health. 
comparable  distribution  and  that  they  emerged  together  with  C3a  (Fig.  4). 
This finding was interpreted to indicate that the C3a fragment liberated by 1 
min of treatment with trypsin at 20°C  is endowed with anaphylatoxin as well 
as  with  chemotactic  activity.  Between  one  and  three  micrograms  of  iso- 
lated C3a were  sufficient to  produce  detectable anaphylatoxin activity. Iden- 1122  C3a  FRAGMENT  OF  THIRD  COMPONENT  OF  HUMAN  COMPLEMENT 
B.  Comparative analysis  of C3a (trypsin)  and C3a produced by other enzymes: 
tical samples of purified C3  were incubated  with  the following  enzymes  un- 
der specified conditions: C3 convertase, C3 inactivator complex, streptokinase 
activated plasmin, thrombin, and trypsin. The treated samples were then ana- 
lyzed by disc electrophoresis at pH 4.5. As seen in Fig.  11,  in each instance a 
basic fragment was liberated and  all basic fragments had similar gel electro- 
phoretic  properties  and  resembled  C3a  (trypsin). 
All  of the  treated  samples,  except  that  containing  thrombin,  had  smooth 
/ 
H  H  H  H  H 
C3a  C3a 
Cony.  Try. 
/ 
J 
H  H 
C3a 
Try. 
FIG. 12.  Identity of biological activity of C3a produced by trypsin and by C3 convertase, 
demonstrated by unresponsiveness of a segment of guinea pig ileum to C3a (trypsin) after 
desensitization with C3a (C3 convertase). That the trypsin-produced C3a had smooth muscle 
contracting activity is shown by effect on a separate segment of guinea pig ileum. H indicates 
the effect of histamine. 
muscle contracting activity. Application of C3a, liberated by the action of C3 
convertase,  to the guinea pig ileum produced  tachyphylaxis and desensitized 
the muscle to the effect of C3a (trypsin)  (Fig. 12),  indicating identical biologic 
specificity of the two fragments. A  desensitized muscle, however, retained full 
reactivity to C5 derived anaphylatoxin. In view of the finding of chemotactic 
activity in C3a (trypsin), the C3a fragments produced by C3  convertase and 
by the C3 inactivator complex were isolated and tested. Both preparations were 
found to be chemotactically active (Table III). Definite chemotactic activity 
was also found in  the basic fragment obtained by short time treatment with 
plasmin. 
C.  Inhibition of C3 derived anaphylatoxin  by anti-C3 and anti-C3a: Approxi- 
mately 20 ~g of low tool wt material with anaphylatoxin activity was added to 
0.5  ml of anti-C3 and to 0.5 ml of a  normal  rabbit serum,  respectively. After 
30 rain at 32°C,  smooth muscle contracting activity was tested. As shown in V.  A.  BOKISCH, H.  J.  MULLER-EBF.RHARD~ C.  G.  COCHRANE  1123 
Fig. 13, anti-C3 completely abolished the anaphylatoxin effect, whereas normal 
rabbit serum did not noticeably interfere with the activity. Complete inhibition 
was also obtained in several experiments with an antiserum to C3a. 
TABLE III 
Comparison of Chemotacti~ Activities Generated from C3 with Trypsin, C3 Convertase, and C3 
Inactivator Complex 
Sample  Treatment  Chemotacfic  value 
1 rag 
C3 
C3 
C3 
Trypsin, 10/~g, 20°C, 5 rain* 
Trypsin, 10/zg, 20°C, 5 rain* 
C3 convertase 
C3 convertase 
C3 inactivator complex 
C3 inactivator complex 
llo:l: 
82 
184:1: 
98 
35t:~ 
88 
* 20 #g soybean trypsin inhibitor added after treatment. 
Corrected for background activity of same amount of untreated C3. 
C3a 
Anti-C3 
7 
C3a 
NRS  NRS 
H 
Fio. 13. Inhibition of anaphylatoxin activity by anti-C3 antiserum. 10 #g C3a were incu- 
bated with 0.2 ml of rabbit anti-human C3 or with 0.2 ml normal rabbit serum for 30 rain at 
32°C, after which the mixtures were applied to the guinea pig ileum. H indicates the effect of 
histamine. 
IlL  Description and Partial Purification of an Inaaivator in Human Serum 
of C3- and C5-Derived Anaphylatoxin.-- 
Addition of isolated C3a to samples of human serum resulted, within a  few 
rain, in total loss of its smooth muscle contracting activity. The inactivator of 
anaphylatoxin was shown to be a pseudoglobulin and to migrate, upon Pevikon 1124  c3a  FRAGMENT  OF  TIHRD  COMPONENT  OF  HUMAN  COMPLEMENT 
electrophoresis  at  pH  8.6,  as an a-globulin  (Fig.  14).  Upon  sucrose  density 
gradient ultracentrifugation, it sedimented with an s rate of approximately 10S. 
When the a-globulin fraction of the pseudoglobulins was submitted to further 
fractionation  on a  Sephadex  G-200 column,  the inactivator  emerged  slightly 
earlier than a 9.5S reference protein (Fig. 15). The active material  from Sepha 
it  A 
......  i 
i°" 
-S  o.2- 
t  fo  1~  2'o  ~s  3'o  3'5  do 
Fraction  Humber 
FIO. 14.  Localization of anaphylatoxin inactivator in electrophoretic fraction of the pseudo 
globulins of human serum. Pevikon block; barbital buffer, pH 8.6,  T/2  =  0.05; 24 hr; 3-4 
v/cm. Arrow indicates origin; anode was at the right. Fractions 26-30 which contained the 
nactivator were pooled and concentrated for Sephadex filtration.  ~  ~i] 
i  / 
0.4  Anapbylato~  Inactivatien : 
CSa-  +  +  +  -!  ..... 
CSa-  +  +  +  / 
."  .  ,  .  •  .... 
2O  3"O  4"0  50  6"0  7"O  a'O  gO  1dO 
Fraction Number 
FIG. 15.  Localization of  anaphylatoxin  inactivator  in  fractions  obtained  by  Sephadex 
G-200 filtration of active material from Pevikon block (Fig. 14). The column was equilibrated 
with 0.15 x  Tris buffer, pH 8.0. C3a, C5a and lysyl bradyklnln were inactivated by the same 
fractions. V.  A.  BOKISCH~  H.  J'.  MOLLER-EBERHARD,  C.  G.  COCHRANE  1125 
dex filtration was concentrated and subjected to disc electrophoresis at pH 8.7. 
Five protein bands could clearly be seen. Anaphylatoxin inactivator activity 
could be eluted from segments  of unstained gels which  corresponded  to the 
position of one of the five protein bands. Further work is needed to isolate the 
inactivator. 
The partially purified  anaphylatoxin inactivator was found to be rapidly 
inactivated on heating at 56°C, but to be unaffected by soybean trypsin in- 
hibitor or by incubation with 5 X  10  -~ ~ DFP. Its action on anaphylatoxin was 
dependent on time, temperature and pH; pH 5 and 0°C inhibited inactivation, 
whereas treatment for 5 min at room temperature at pH 7 or 8 led to inactiva- 
tion of even a large molar excess of C3a (at least 100-fold). Evidence for binding 
of C3a by the inactivating factor could not be obtained, l~SI-labeled C3a (pre- 
TABLE IV 
Properties of Anat~kylatoxin lnacti~ator 
Solubility  at ~  =- 0.02, pH 5.4 
Electrophoretic mobility  at pH 8.6 
Sedimentation velocity 
Activity 
Soluble (pseudoglobulin) 
a-globulin 
Approximately  10S 
Thermolabile (30 rain, 56°C) 
pH dependent (pH 7-8) 
Temperature dependent 
Not inhibited by DFP or soybean trypsin 
inhibitor 
w 
pared either by trypsin, C4,2 or the C3 inacfivator complex) exhibited the 
same ultracentrifugal behavior after inactivation by anaphylatoxin inactivator 
as  untreated C3a  controls.  The radioactive material sedimented with an s 
rate  of  1-1.2S. The present evidence  suggests  an  enzymatic mechanism of 
anaphylatoxin inactivation. The properties  of the inactivator are summarized 
in Table IV. 
That  the 10S a-globulin  described here has more general  significance as a 
regulatory factor is indicated by two further observations.  As illustrated in 
Fig. 1S, column fractions containing the C3a inactivator also effected destruc- 
tion of C5a anaphylatoxin and abolition of lysyl bradykinin activity. 
DISCUSSION 
Recent work has shown that anaphylatoxin and chemotactic activity  may be 
generated from C3 and C5.  The development of this area of research and, in 
particular, the original evidence showing that these activities reside in low mol 
wt fragments of the respective  complement components  were recounted in a 
recently published  review (18). Additional evidence in support of this concept 
was reported lately from several laboratories  (3,  20, 21). 
The present paper contributes to the available  information the following 1126  c3a  FRAGMENT  OF  THIRD  COMPONENT  OF  HUMAN  COM:PLEM.ENT 
data and insights pertaining especially  to formation, characteristics, isolation, 
and control of the biologically  active C3 fragments. The percursor molecule, 
C3,  possesses,  in its native state, a highly susceptible region  for attack by a 
variety  of  enzymes,  including  trypsin,  thrombin,  and  plasmin.  Enzymatic 
cleavage within  this region  leads to dissociation  of a  very basic, low mol wt 
fragment designated C3a. It was possible in this study to demonstrate C3a, for 
the first time directly as a protein entity, using acid polyacrylamide gel electro- 
phoresis and to isolate the material in sufficient  amounts for ultracentrifugal 
and electrophoretic analysis and for initiation of work on the structure of the 
protein, the results of which will be published elsewhere (15). Whereas anaphy- 
latoxin  activity has  been derived from  C3  heretofore only by means  of C3 
convertase or C3 inactivator complex,  the present investigations showed that 
also trypsin and plasmin are able to liberate biologically  active C3a and that 
thrombin  sets free a  very similar  fragment  which,  however,  was  devoid of 
smooth muscle contracting activity. 
Trypsin was particularly efficient in liberating C3a; the reaction approached 
completion  within  sec at  room temperature  even  at  relatively low enzyme 
concentrations. The piece removed by trypsin closely resembled C3a produced 
by C3 convertase in its behavior on disc electrophoresis,  Sephadex filtration, 
and also with respect to its biological activity. It rendered the guinea pig ileum 
unresponsive to C3a (C3 convertase) but not to C5a anaphylatoxin (4). As will 
be reported elsewhere  (15), the mol wts and amino acid compositions of C3a 
(trypsin) and C3a (C3 convertase) were exceedingly similar.  Nevertheless, the 
two fragments differed in their C-terminal amino acid residues,  indicating that 
the two enzymes cleave different bonds in  the susceptible region  of the  C3 
molecule. The close similarity between the two C3a fragments was also revealed 
by their yielding a reaction of identity with anti-C3 or anti-C3a in Ouchterlony 
plates. Furthermore, the anaphylatoxin activity of both could be inhibited with 
either of the two antisera. 
Treatment  of active C3a with trypsin rapidly abolished anaphylatoxin  ac- 
tivity and caused the originally  basic fragment to become negatively charged 
and to assume the electrophoretic mobility of a E-globulin. Since Ward (6) had 
previously demonstrated a chemotactically active anionic fragment of C3 after 
prolonged treatment of the protein with an equal amount of plasmin,  the ques- 
tion was raised as to whether C3a might be chemotactic for polymorphonuclear 
leukocytes. It was clearly shown that  the basic C3a fragment with anaphy- 
latoxin activity also had chemotactic activity, irrespective of the type of enzyme 
used for its dissociation.  However, unlike the smooth muscle contracting  ac- 
tivity, the chemotactic activity persisted when C3a upon treatment with tryp- 
sin  assumed a  negative electrophoretic mobility. This finding  indicated  that 
both  activities are a  function of C3a,  although  of different chemical groups 
within the fragment, anaphylatoxin activity being apparently dependent upon V.  A.  BOKISCH,  H.  J.  MOLLER-EBERHARD, C.  G.  COCHRANE  1127 
positively charged groups. The finding further suggested that the chemotactic 
C3 fragment described by Ward which was devoid of smooth muscle contract- 
ing activity is a  degradation product of C3a. This view is supported by the 
observation that brief treatment of C 3 with plasmin gives rise to a basic frag- 
ment with anaphylatoxin as well as chemotactic activity. 
In addition to formation and degradation of C3a, trypsin effects cleavage of 
the major fragment, C3b, into at least two antigenically distinct pieces, which 
were called C3c and C3d. This reaction proceeded with relative ease, being 
completed within 60 rain at 37°C. The two pieces could readily be separated 
from each other utilizing their difference in size. Their availability will facilitate 
structural studies of C3, particularly in conjunction with studies of the chemi- 
cal dissociation of the molecule by methods recently elaborated in this labora- 
tory.  4 Material indistinguishable from the c- and d-fragments was obtained by 
treatment of C3b with thrombin or with plasmin. However, the efficiency of 
these enzymes in cleaving C3b was much lower than that of trypsin. There is 
no evidence to date that C3 convertase can cleave C3b; its high degree of sub- 
strate  specificity apparently limits the  enzyme to  action on the  susceptible 
region of native C3. 
Aging of whole serum or brief incubation of fresh serum with antigen-anti- 
body complexes was shown previously to result in conversion of C3 to C3i and 
in cleavage of C3i into 01A- and am-globulin (22, 23). The present results indi- 
cate that C3i consists of a loose complex of C3a and C3b which may become 
completely dissociated at low pH. O~-globulin appears  to be  identical with 
C3c and am with C3d. Considering also the secondary changes which C3a under- 
goes after its formation in serum, an antigen-antibody reaction in human serum 
may affect C3 in the following manner: 
C4,2 
C3  ,  C3a,b  (1) 
Anaphylatoxin  Inactivator 
C3a'  ~ (C3a)i  (2a) 
Serum enzyme 
C3b  ~ C3c +  C3d  (2b) 
where C3a, b  represents the associated form of the a- and b-fragment, which 
is prevalent at pH 7; where (C3a)i is the biologically inactive product of C3a 
and where "serum enzyme" is a noncomplement enzyme which may be throm- 
bin. 
The identity of the anaphylatoxin inactivator encountered in human serum 
is as yet uncertain.  Circumstantial evidence for its existence had been pre- 
sented by Dias Da Silva and Lepow, who were unable to generate anaphy- 
latoxin activity with several fresh human sera tested (24). Lately, Lepow and 
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Patrick (25) reported direct evidence for an inactivator in human serum and 
suggested  that the inactivator acts by forming  a  complex with C3a  rather 
than by acting on  it  enzymatlcally. The  10S a-globulin  described  in  this 
paper appears  to act differently.  It does not seem to neutralize C3a anaphy- 
latoxin through the formation of an anaphylatoxin-inactivator  complex. Rather, 
the  conditions  of the neutralization reaction suggest  an enzymatic process. 
The inactivator is not strictly specific for C3a, but abolishes also the activities 
of CSa anaphylatoxin and of lysyl bradykinin. In view of the latter observa- 
tion, the question arose as to whether the 10 S a-globulin  might be identical 
with serum kinlnase,  i.e., carboxypeptidase N  (26). Since information on the 
physicochemical properties  of carboxypeptidase N is limited (27) and since a 
10S inter-a-globulin  has not been described as a constituent of human serum 
(28), further work on this serum component is needed.  Chemical  studies are 
underway to define the effect of the inactivator on both anaphylatoxins and 
on lysyl bradyklnin. 
SUMMARY 
A small fragment of C3, called C3a, which has smooth muscle contracting 
activity, was isolated  by three different methods. At pH 8.6, C3a behaved as 
cation, and using the Archibald method, its tool wt was determined to be 7000. 
A specific antiserum to C3a showed the fragment to be antigenically distinct 
from the rest of the C3 molecule, i.e., the C3b portion. The same antiserum 
and an anti-whole C3 were able to inhibit the biologic activity of C3a. In addi- 
tion to anaphylatoxin activity, leukocyte chemotactic activity was shown  to 
reside in C3a. Treatment with trypsin caused the cationic fragment to become 
anionic and abolished the anaphylatoxin but not the chemotactic activity. 
C3a  fragments  with  identical  biologic  activity and  comparable  cationic 
properties,  as determined by acid disc electrophoresis, were obtained by treat- 
ment of C3 with C3 convertase,  C3 inactivator complex, trypsin, and plasmin. 
Thrombin produced a similar C3 fragment which was inactive. It was concluded 
that C3a corresponds to an unusually basic portion of C3 which may be liber- 
ated by attack of a variety of enzymes on a highly susceptible  region of the 
native C3 molecule. 
C3b was cleaved by trypsin and less efficiently by thrombin or plasmin into 
two antigenically distinct pieces:  the larger  C3c fragment corresponding  to 
~IA and the smaller C3d fragment to am of aged serum. The c- and the d-frag- 
ments were separated and characterized. 
Isolated  C3a  rapidly lost  its  anaphylatoxin activity when  treated  with 
small  amounts of a  partially purified,  thermolabile  10S a-pseudoglobulin  of 
human serum.  The conditions  of inactivation suggested  an enzymatic reac- 
tion. The anaphylatoxln inactivator also destroyed the activity of C5-deHved 
anaphylatoxin and of lysyl bradykinin. 
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